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D 4.11 General Issues Relating to Surgical Treatment
D 4.11.1 Anesthesia
Either general or regional anesthesia may be used for lower-extremity bypass grafts. Some cen-
ters advocate the use of a combination of both techniques for aortic surgery for optimal patient
comfort and minimal respiratory depression. There have been reports of increased distal graft
patency when epidural/spinal anesthesia arc used. However, the results of a recent randomized
control trial failed to show any effect of the type of anesthesia on the 3D-day patency rate of
infrainguinal bypass grafts.'
The choice and conduct of the anesthetic technique is more important in the transabdominal
aortoiliac reconstructions. All inhalation anesthetics are myocardial depressants; intravenous nar-
cotic analgesics such as fentanyl are often used as an alternative to inhalation anesthetics because
they produce minimal myocardial depression. However, large doses of narcotics may be neces-
sary to avoid hypertension during intraabdorninal procedures, and as a consequence may pro-
duce ventilatory depression. Spinal or epidural anesthesia has no direct effect on the myocardi-
um but may increase myocardial oxygen consumption because they may be associated with
hypertension and bradycardia resulting from sympathetic blockade. Prospective studies that have
compared general and epidural anesthesia have found no advantage to either technique in
reducing perioperative cardiac complications in patients undergoing aortic surgery or infrain-
guinal procedurcs.t-' Systemic anticoagulation is not a contraindication for epidural anesthesia if
begun after catheter placement, although it is uncertain how long a delay is necessaryafter
catheter placement before anticoagulation can be instituted.v
D 4.11.2 Antibiotic Prophylaxis for Vascular Procedures
It is generally believed that graft contamination occurs most commonly at the time of the origi-
nal operation. This emphasizes the importance of a meticulous sterile technique with avoidance
of skin contact by the use of adherent plastic drapes. Several randomized studies have now
demonstrated the efficacy of antibiotic prophylaxis in reducing the incidence of vascular graft
infection, and its perioperative use is now well accepted.5,6 There is evidence that antibiotic pro-
phylaxis should continue until drains and invasive monitoring lines are removed. 6,7 The same
principles of sterile techniques must apply to endovascular procedures with stent implantation,
evidence that the same principles should apply to stents. Covered stents should be treated as
prosthetic grafts in terms of use of prophylactic antibiotics. However, the need for and effective-
ness of antibiotic prophylaxis with other endovascular techniques is unknown .8,9,10,11
Recommendation 94: Use of prophylactic antibiotics with prosthetic grafts
Patients undergoing prosthetic grafts should have prophylactic antibiotic therapy peri-
operatively.
Critical Issue 36: Duration of prophylactic antibiotics with prosthetic grafts
There is a need for more data to determine how long antibiotic prophylaxis is required
when prosthetic grafts are implanted.
D 4.11.3 Perioperative Care of the Diabetic Patient
Ideally, blood sugar should be normalized in the diabetic patient before surgical intervention .
This may involve the switch from oral agents to insulin in some patients. The control of sepsis
in the diabetic foot may help control hyperglycemia and ketoacidosis. Particular attention to the
renal function is needed in patients with diabetes, because investigations such as angiography
may lead to deterioration. The rationale for striving to achieve ncar-normal glucose has been
established, but other factors must be considered in patients with diabetes who must undergo
surgery with less than optimal control of metabolism in an acute situation. Such patients can be
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hemodynamically unstable during anesthesia because of dehydration and osmotic shifts.
Furthermore, such patients are more prone to infection, have decreased wound healing, and
may have increased free fatty acids, the metabolism of which increases myocardial oxygen con-
sumption.12,13
D 4.11.4 Treatment of the Failing Graft
The concept of the "failing graft" has been emphasized by several series documenting improved
results when intervention is directed at the time when the graft is still patent, that is, failing
rather than failed. Graft surveillance is necessary to detect a failing graft at this preocclusive
stage. The details are dealt with in D 4.14, Surveillance After Revascularization (p 5253). Grafts
may fail on the basis of intrinsic graft pathology or pathology in the inflow or outflow segments.
Inflow and outflow lesions should be managed according to the principles outlined elsewhere in
this document. Graft stenoses can be managed by either interposition or jump graft segmental
bypass or patch angioplasty, depending on the length of the lesion. Debate continues, but cur-
rent opinion favors segmental bypass or patch angioplasty rather than percutaneous balloon
angioplasty for most lesions.
D 4.11.5 Treatment of Graft Thrombosis: The Failed Graft
The choice between thrombolysis and thrombectomy for graft occlusion is complicated by the
fact that these tend to be linked with PTA and surgical revascularization, respectively, in trials.
As a result of this and also of a significant technical failure rate, four major trials have failed to
show an overall advantage for thrombolysis on an intent-to-treat basis,l4,lS,16,17 However, its
obvious potential advantages (stated previously) and the relative ease of the procedure probably
can be achieved only by selective application. Although urgent thrombectomy may be required
for immediate limb threat, and surgical reconstruction is preferred in delayed occlusions (>14
days' duration), thrombolysis holds the advantages in terms of mortality and amputation for less
than 14 days' occlusion.H- 17This complex subject is dealt with in more detail in C 4.2.2,
Contraindications to Thrombolysis, p 5152.
Open surgical procedures have been the traditional approach for bypass graft occlusion, direct-
ing procedures at thrombectomy, and revision or replacement of the existing graft, with the lat-
ter giving best results,l8,19,20 Thrombolysis has been advocated as a less invasive, alternative
means of restoring graft function that also provides the opportunity to unmask stenotic lesions
responsible for the occlusive event and to clear the run-offvessels.21,22 The unmasked lesion is
then addressed with an endovascular or operative approach after successful thrombolysis, the
choice depending on the characteristics of the lesion (eg, neointimal hyperplasia or diffuse or
local atherosclerotic involvement). The most appropriate treatment for a valve cusp stenosis is
operative patching or resection and reconstruction. The results for open repair are believed to
be superior to dilatation and yield excellent secondary patency rates.23 If the distal anastomosis
is involved or should there be progression of disease, there may be a need to extend the bypass
graft. Whatever method is used, good success rates have been achieved with the use of alterna-
tive vein sources. 23 If an established bypass graft fails less than 6 months after construction, then
graft replacement of this disadvantaged conduit is indicated.et
Recommendation 95: Treatment of chronic critical leg ischemia due to bypass ~aft occlusion
In patients with chronic critical leg ischemia, surgical revision or graft replacement is
the preferred treatment for bypass graft occlusion. Thrombolysis may be considered as a
treatment option in patients who present early after their bypass graft occlusion where
the limb is not immediately threatened.
The treatment strategy for bypass graft occlusion must be tailored to the clinical setting and the
risks and benefits associated with the therapeutic options. In addition to the characteristics of
the underlying lesion, the parameters that are important in determining appropriate therapy
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include the severity of the patients' symptoms, the duration of the occlusion, and the nature of
occluded conduit (autogenous or prosthetic). For instance, in patients with occluded lower-limb
grafts who present with sudden-onset claudication , the clinician will need to consider the origi-
nal indications for the graft and possible future surgical options if no attempt is made to rescue
the graft .
D 4.11.6 General Complications of Surgical Intervention
Cardiac mortality and morbidity
The most common source. of morbidity and mortality after revascularization for PAD is myocar-
dial ischemia. Although operative mortality is decreasing steadily, long-term survival of these
patients continues to be compromised. The cumulative long-term survival is 40% to 50% at 10
years. Patients with CLI, extensive arterial disease, or diabetes have a less favorable long-term
prognosis than patients with localized disease and claudication. Most late deaths are also attrib-
uted to atherosclerotic heart disease.2s (see A 2.7, Fate of Patients With CLI , p 523 ). Other
specific complications are outlined in the following paragraphs.
Deep vein thrombosis
A randomized prospecti ve trial of deep venous thrombosis (DVf) prophylaxis in aortic surgery
failed to show any increased incidence after aortic surgery in the control group compared with
the prophylaxis group.26 A second study reported a DVT incidence of9 .8%in patients undergo-
ing either aortic or distal revascularization (with the highest incidence following amputarioni.F
All patients in this study had received DVT prophylaxis. Therefore, although pharmacotherapy
to avoid arteri al th rombosis after rcvascularization also frequently reduces the risk of DVT, this
risk cannot be neglected entirely.
D 4.11.7 Complications of Aortoiliac Reconstruction
Currently, excellent early and late results of direct aortoi liofemoral reconstru ctions for occlusive
disease can be anticipated . Perioperative mortality rates are well under 3%in many centers, and
patency rates of close to 85% at 5 years and 75%at 10 years are expected,28,29 Though some-
what dated, a list of complications of aortoiliac reconstruction other than graft failure are sum-
marized in Table 52.
Table 52. Complication of ao rto-iliac bypass grafts
Complication
Myocardial Infarction30,31
Death 32,33.34.35,36,37.38
In testi nal ischcrnia-?
Ren al failure40•41,42.43
Urete ral injury44
Sp inal cord ischell1ia,45,46
Graft infection41.17.48
Ao rtoenteric fistula 47,4M
Lymph fistula49
False aneu rysms?,48,50,51,52
Alt ered sexual ftmction53
Incidence (%)
0.8-5 .2
0-3.3
1.1
0-4.6
1.6
0.25
0.1-1.3
0.1-0.5
1.5-3 .5
3- 5
20
Etiology/Commmu
Concurrent cardiac disease
Usually myocardial
Ligation IMA-eolonic
Preexisting SMA disease
Preex isting renal dysfunction increases risk
f requent association with graft complication
Arheroernboli, occlusion vascular supply
Hi gher incidence involving groin anastomosis
Erosion, lack of reperi ronealizarion,
aortic false aneurysms
Di vision of lymphatics
Infection, native artery degeneratio n
Acute complications; limb ischemia
Acute limb ischemia occurring shortl y after aortic operation for occlusive disease is generally
attributable to acute thrombosis of the graft or one of its limbs and occurs in 1%to 3% of
patients. The main causes are twisting , kinking of the graft limb, or technical problems at the
distal femor al anastomosis site. Acute limb ischemia also can occur as a result of intraoperative
thromboembolic events, all related to technique and all preventable .
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Intestinal ischemia
Intestinal ischemia is more likely after aortic surgery for aneurysmal disease than after that for
PAD but may occur after the latter. A large or meandering inferior mesenteric artery (rMA)
with upward flow warns of concomitant celiac or superior mesenteric artery (SMA) disease
deserving attention and mandates IMA preservation. Otherwise, preservation of hypogastric
internal iliac artery outflow is the key to avoiding intestinal ischemia, impotence, or paraplegia
(see next paragraphj.I? As discussed earlier, this may dictate the choice between proximal end-
to-side and end-to-end anastomosis.
Erectile impotence
The incidence of iatrogenic erectile impotence after aortic reconstruction may approach 25%.
Most often, impotence implies inadequate preservation of the hypogastric artery and pelvic circu-
lation. Retrograde ejaculation is also a frequent occurrence and is attributable to disturbance of
autonomic nerve fibers that course along the left wall of the aorta and cross the common iliac
arteries. As described by De Palma et al,54 a nerve-sparing approach to the infrarenal aorta is
helpful, and preservation of the hypogastric artery flow by a variety of techniques is also essential.
Anastomotic false aneurysms
The incidence of anastomotic false aneurysm formation after aortoiliac reconstruction varies
from 1% to 5% and is by far most common at the femoral anastomosis.Sf Previously these were
related to the use of silk sutures and, rarely, prosthetic suture material may fracture.
Degenerative changes within the host arterial wall leading to weakness and dehiscence of the
intact suture line appear to be the most common cause. Infection may be a contributing cause
and always needs to be considered as a possible causative factor. 56
The true incidence of proximal aortic anastomotic aneurysm may be higher than previously
thought after aortic surgery for PAD; a study by Edwards et al57 reported a 10% incidence, of
mostly asymptomatic anastomotic aneurysms, at a mean interval of 12 years after initial revascu-
larization. These anastomotic aortic aneurysms are more common after lateral anastomosis than
after end-to-end anastomosis. This suggests that CT scans should be a routine part of the late
follow-up of patients with an aortic graft, that is, beginning at 3 years postintervention.
Aortoiliac, aortojemoralgraft infection
The incidence of graft infection is between 1%and 5% after aortic surgery. It may be difficult to
prove unequivocally that a graft is infected. Despite this, all efforts should be made to deter-
mine whether a perigraft collection is present, whether graft infection is likely, and which infect-
ing organisms are involved. Once this has been determined, the likelihood of infection must be
balanced against the general condition of the patient, the extent of revision surgery, and the
necessity for immediate intervention.
The organisms most commonly isolated from blood or from wounds are Pseudomonas,
Staphylococcus, and streptococcus species. Computed tomography scanning and magnetic reso-
nance imaging are very helpful in demonstrating fluid collections around a suspect aortic graft.
Labeled white cell scans also can be useful if performed more than 4 weeks after smgery.
Treatment of aortic graft infection is challenging. Graft conservation with local debridement of
infected tissue followed by local irrigation with antibiotics has been advocated by some authors.f"
However, many authors believe that most graft infections involve the whole length of the pros-
thesis, even though presentation or imaging may suggest a local sepsis. Graft excision has been
recommended by most authors. This decision should be made carefully, and, whenever possible,
the patient's condition needs to be optimized before surgery.59 After excision, extensive
retroperitoneal debridement must be done. A number of recent reports have advocated direct in
situ replacement with a rifampin-soaked Dacron or PTPE graft. However, these selected excep-
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tions to the generally accepted policy of complete graft excision and exrraanatornic bypass pri-
marily involve late indolent infections with Staphylococcus epidcl'midis with little associated sys-
temic sepsis. Placement of a graft in a site that is potentially infected might result in higher risk
of future reinfection .sv
Autogenous vein grafts provide an alternative to prosthetic material tor in situ reconstruction,
but sufficient vein is difficult to obtain, and this technique is not practiced widcly.s! However,
recently good experiences have been reported with the use of the superficial femoral vein for
this purpose, because size mismatch is less ofa problem.62,63 The consequences of harvesting
this vein have been surprisingly mild. 64 Cryopreserved hornografrs to reconstruct the aortoiliac
anatomy have recently been advocated for replacement of infected aortic prosthetic grafts.
Concern regarding long-term dilatation remain, although they seem resistant to reinfection.of
When complete graft excision with extraanaromic reconstruction using bilateral axillounifemoral
bypasses is not feasible because of extensive groinythigh sepsis or previous extraanatomic bypass
failure, in situ reconstruction using (superficial femoral or popliteal) veins may be the only
remaining option . However, because of its significant mortality and morbidity, it is reserved tor
situations in which life or limb loss would probably result without revascularization.v-. 64,65,66
Some experience has been achieved using in situ allograft replacernent.s?
D 4.11.8 Complications of Infrainguinal Vein Bypass Grafting (Table 53)
Table 53. Complications of infrainguinal bypass
Complication
Death58,69
Myocardial infarctiOl168,84
Wound:
Vdn69,74,75
Prosthctic/!
Exposurcyblowours?
Infection:
Vein"!
PTFE/Dacrun 71
HlN 7 1
Leg edeman
Lymph leak49 ,73
Acute limb ischemia
Incidence (%)
1.3-6
1.9-3.4
10-30
18
9.5/1.6
1.36
3.56
1.48
50-100
0.5-1.8
1-2
Eti%gyjclJtnmClltS
Usually cardiac
Resolution usually by 4 months
Lower with fernoral d istal than with
aortofemoral
Wound complications
The in situ technique has a recorded wound complication rate of 10% to 30%, with most prob-
lems occurring in the distal wound or the mid thigh,74,75 Meticulous dissection without cre-
ation of flaps and tension-free closure are emphasized to reduce this complication. A retrospec-
tive comparative study showed that the in situ technique was associated with a higher rate of
wound complications than nonreversed or reversed subcutaneously placed long saphenous vein
grafts (23% vs. 9.3%). A continuous incision was also associated with higher rates of wound
complications.Z? A prospective randomized trial, however, failed to confirm this difference in
wound complications seen in sin! (15%) and reversed vein( 17%) graft reconstructions.v?
Arteriovenous fistula
These are avoided by on table graft assessment (angiogram, Doppler assessment) but occasional-
ly become apparent after the operation. Arteriovenous fistulae may be treated by ligation or
embolization under local anesthetic,
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Legswelling
Leg swelling after revascularization is an accepted complication of any infrainguinal bypass. The
origin of the swelling has been investigated and found to be related to the lymphatic disruption
and interruption in the groin along the path of vein harvest and increased lymph production
during postoperative reactive hyperemia.Z'V?
Early graft occlusion
Early failure rates have been reported to be as high as 17% for grafts to the popliteal artery and
24% for grafts to more distal arteries and is related to technical failure (eg, missed valve cusp,
twist, anastomotic error).78,79,80,81 In 63% of the graft failures in one study, the cause was
intrinsic to the graft or anastomosis.Zf Early graft thrombosis is usually attributed to technical
error, hypercoagulable state, or periods of hypotension or hypoperfusion, A randomized trial
reported the benefit of Dextran 40 in preventing early graft thrombosis of "difficult" distal
bypasses.82 The I-week occlusion rate was 20.5% in the control group and 6.9% (0% in vein
grafts) in the Dextran 40 group. The overall early graft occlusion rate can be reduced by good
technique, intraoperative monitoring of the completed bypass, and adjuvant therapy (see D
4.13, Adjuvant Therapy After Revascularization p 5247; D 4.14, Surveillance After
Revascularization, p 5253).
Hemodynamic failure
This may be said to occur when limb viability is threatened or not reversed even in the face of a
patent bypass graft. Occasionally, limb loss may occur despite a patent graft. The current objec-
tive criteria for hemodynamic failure is failure to increase the ABPI or toe:brachial index more
than 0.10. 83
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